in silico identification and conservation analysis of b-cell and t-cell epitopes of hepatitis c virus 3a genotype enveloped glycoprotein 2 from pakistan: a step towards heterologous vaccine design

conclusions hcv gpe2 is an ideal target for hcv vaccine. prediction of epitope immunogenicity and characterization on the basis of peptide sequences will be significantly helpful for development of a heterologous vaccine against hcv variants. results many b-cell and t-cell epitopes predicted in gpe2 were found conserved among hcv 3a genotypes whereas few were conserved in other genotypes anticipating these epitopes as potential candidates of producing strong b-cell and t-cell response against hcv 3a and other genotypes. materials and methods epitope finding was done by using online available bioinformatics tools including immune epitope database (iedb), propred-i, and propred. conservation of these epitopes was found by aligning selected gpe2 sequences using multalin online software and conservancy analysis tool available at iedb. objectives this study focused on b-cells and t-cells epitopes prediction in hcv gpe2, particularly in 3a genotype, in pakistan and identification of the conserved epitopes among various 3a isolates at global level, principally conserved across hcv major genotypes. background hepatitis c virus (hcv) is known for the eminent global disease burden responsible for encumbering public health. development of an effective vaccine is the major need of the day; however, several obstacles loom ahead of this objective. one of the major barriers is that as a rna virus, it mutates rapidly resulting in high sequence divergence and several viral isolates in the world. theglycoprotein 2 (gpe2) is the primary component of hcv envelope with direct interaction with the host cell surface receptors; it is an indispensable target of neutralizing antibodies and hence, should be a fundamental component of vaccine design.